Soma

Soma is a biotechnology company focused on developing a new class of programmable cell therapies designed to treat complex diseases such as autoimmune disorders and cancer. The company utilizes its proprietary Soma Platform to engineer cells with enhanced precision, allowing for better control over cell behavior and therapeutic outcomes. By leveraging advanced synthetic biology and gene editing techniques, Soma aims to overcome the limitations of current cell therapies, such as exhaustion and lack of specificity. The company is currently in the pre-clinical stage, advancing a pipeline of internal and partnered programs aimed at delivering curative treatments.